Croda International (LON:CRDA) Sets New 12-Month Low After Insider Selling

Posted by Patrick Bannon on Mar 27th, 2025

Croda International Plc (LON:CRDA – Get Free Report)’s stock price reached a new 52-week low on Tuesday after an insider sold shares in the company. The stock traded as low as GBX 2,880 ($37.08) and last traded at GBX 2,893 ($37.25), with a volume of 332606 shares. The stock had previously closed at GBX 2,889 ($37.20).

Specifically, insider Steve Foots sold 3,249 shares of the stock in a transaction on Monday, March 24th. The stock was sold at an average price of GBX 2,909 ($37.45), for a total transaction of £94,513.41 ($121,685.86).

Croda International Stock Performance

The company has a market capitalization of £4.10 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. The stock’s fifty day simple moving average is GBX 3,185.85 and its 200-day simple moving average is GBX 3,501.35.

Croda International (LON:CRDA – Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.84) EPS for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. As a group, equities analysts predict that Croda International Plc will post 181.8307268 earnings per share for the current year.

Croda International Increases Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 28th. Investors of record on Thursday, April 10th will be given a dividend of GBX 63 ($0.81) per share. The ex-dividend date is Thursday, April 10th. This is an increase from Croda International’s previous dividend of $47.00. This represents a yield of 2.03%. Croda International’s dividend payout ratio is 93.66%.

About Croda International

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.